"The Joint venture with Globe Med Tech is clearly a win-win situation. It brings together two companies with diverse backgrounds with distinct strengths, allowing both parties to focus on their forte. Globe will continue to evaluate new safety products and patents and will attempt to bring related products and technologies to the Joint Venture," stated Ron Wheet, CEO of Maxxon.
Maxxon is a development-stage company committed to reducing the risk of accidental needlestick injuries and deaths to healthcare workers. Maxxon's 3cc safety syringe, presently in development, is designed as a single-handed, vacuum-operated safety syringe that retracts the used needle into the syringe after use.
Globe Med Tech, Inc. is a high-tech medical safety and drug delivery products developer and manufacturer based in
Source: Maxxon, Inc.